BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 29499331)

  • 1. Systemic administration of scAAV9-IGF1 extends survival in SOD1
    Wang W; Wen D; Duan W; Yin J; Cui C; Wang Y; Li Z; Liu Y; Li C
    Brain Res Bull; 2018 May; 139():203-210. PubMed ID: 29499331
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of the stress-activated MAP kinase, p38, but not JNK in cortical motor neurons during early presymptomatic stages of amyotrophic lateral sclerosis in transgenic mice.
    Holasek SS; Wengenack TM; Kandimalla KK; Montano C; Gregor DM; Curran GL; Poduslo JF
    Brain Res; 2005 May; 1045(1-2):185-98. PubMed ID: 15910777
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of insulin-like growth factor 1 in ALS cell and mouse models: A mitochondrial protector.
    Wen D; Cui C; Duan W; Wang W; Wang Y; Liu Y; Li Z; Li C
    Brain Res Bull; 2019 Jan; 144():1-13. PubMed ID: 30414993
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intramuscular Delivery of scAAV9-hIGF1 Prolongs Survival in the hSOD1
    Lin H; Hu H; Duan W; Liu Y; Tan G; Li Z; Liu Y; Deng B; Song X; Wang W; Wen D; Wang Y; Li C
    Mol Neurobiol; 2018 Jan; 55(1):682-695. PubMed ID: 27995572
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adipose-derived Stem Cell Conditioned Media Extends Survival time of a mouse model of Amyotrophic Lateral Sclerosis.
    Fontanilla CV; Gu H; Liu Q; Zhu TZ; Zhou C; Johnstone BH; March KL; Pascuzzi RM; Farlow MR; Du Y
    Sci Rep; 2015 Nov; 5():16953. PubMed ID: 26586020
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of the PPARgamma activator pioglitazone on p38 MAP kinase and IkappaBalpha in the spinal cord of a transgenic mouse model of amyotrophic lateral sclerosis.
    Shibata N; Kawaguchi-Niida M; Yamamoto T; Toi S; Hirano A; Kobayashi M
    Neuropathology; 2008 Aug; 28(4):387-98. PubMed ID: 18312546
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Slow Intrathecal Injection of rAAVrh10 Enhances its Transduction of Spinal Cord and Therapeutic Efficacy in a Mutant SOD1 Model of ALS.
    Li D; Liu C; Yang C; Wang D; Wu D; Qi Y; Su Q; Gao G; Xu Z; Guo Y
    Neuroscience; 2017 Dec; 365():192-205. PubMed ID: 29024785
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of p38 mitogen activated protein kinase activation and mutant SOD1(G93A)-induced motor neuron death.
    Dewil M; dela Cruz VF; Van Den Bosch L; Robberecht W
    Neurobiol Dis; 2007 May; 26(2):332-41. PubMed ID: 17346981
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Macrophage-mediated inflammation and glial response in the skeletal muscle of a rat model of familial amyotrophic lateral sclerosis (ALS).
    Van Dyke JM; Smit-Oistad IM; Macrander C; Krakora D; Meyer MG; Suzuki M
    Exp Neurol; 2016 Mar; 277():275-282. PubMed ID: 26775178
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of the p38MAPK cascade is associated with upregulation of TNF alpha receptors in the spinal motor neurons of mouse models of familial ALS.
    Veglianese P; Lo Coco D; Bao Cutrona M; Magnoni R; Pennacchini D; Pozzi B; Gowing G; Julien JP; Tortarolo M; Bendotti C
    Mol Cell Neurosci; 2006 Feb; 31(2):218-31. PubMed ID: 16219474
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibiting p38 MAPK alpha rescues axonal retrograde transport defects in a mouse model of ALS.
    Gibbs KL; Kalmar B; Rhymes ER; Fellows AD; Ahmed M; Whiting P; Davies CH; Greensmith L; Schiavo G
    Cell Death Dis; 2018 May; 9(6):596. PubMed ID: 29789529
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuroprotective effects of JGK-263 in transgenic SOD1-G93A mice of amyotrophic lateral sclerosis.
    Ahn SW; Jeon GS; Kim MJ; Shon JH; Kim JE; Shin JY; Kim SM; Kim SH; Ye IH; Lee KW; Hong YH; Sung JJ
    J Neurol Sci; 2014 May; 340(1-2):112-6. PubMed ID: 24680562
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Widespread and efficient transduction of spinal cord and brain following neonatal AAV injection and potential disease modifying effect in ALS mice.
    Ayers JI; Fromholt S; Sinyavskaya O; Siemienski Z; Rosario AM; Li A; Crosby KW; Cruz PE; DiNunno NM; Janus C; Ceballos-Diaz C; Borchelt DR; Golde TE; Chakrabarty P; Levites Y
    Mol Ther; 2015 Jan; 23(1):53-62. PubMed ID: 25228069
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ablation of P2X7 receptor exacerbates gliosis and motoneuron death in the SOD1-G93A mouse model of amyotrophic lateral sclerosis.
    Apolloni S; Amadio S; Montilli C; Volonté C; D'Ambrosi N
    Hum Mol Genet; 2013 Oct; 22(20):4102-16. PubMed ID: 23736299
    [TBL] [Abstract][Full Text] [Related]  

  • 15. GLT1 overexpression in SOD1(G93A) mouse cervical spinal cord does not preserve diaphragm function or extend disease.
    Li K; Hala TJ; Seetharam S; Poulsen DJ; Wright MC; Lepore AC
    Neurobiol Dis; 2015 Jun; 78():12-23. PubMed ID: 25818008
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intrathecal Injection of scAAV9-hIGF1 Prolongs the Survival of ALS Model Mice by Inhibiting the NF-kB Pathway.
    Hu H; Lin H; Duan W; Cui C; Li Z; Liu Y; Wang W; Wen D; Wang Y; Li C
    Neuroscience; 2018 Jun; 381():1-10. PubMed ID: 29447858
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mislocalization of TDP-43 in the G93A mutant SOD1 transgenic mouse model of ALS.
    Shan X; Vocadlo D; Krieger C
    Neurosci Lett; 2009 Jul; 458(2):70-4. PubMed ID: 19379791
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Actions of the antihistaminergic clemastine on presymptomatic SOD1-G93A mice ameliorate ALS disease progression.
    Apolloni S; Fabbrizio P; Amadio S; Volonté C
    J Neuroinflammation; 2016 Aug; 13(1):191. PubMed ID: 27549088
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interleukin-6 Deficiency Does Not Affect Motor Neuron Disease Caused by Superoxide Dismutase 1 Mutation.
    Han Y; Ripley B; Serada S; Naka T; Fujimoto M
    PLoS One; 2016; 11(4):e0153399. PubMed ID: 27070121
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Guanabenz delays the onset of disease symptoms, extends lifespan, improves motor performance and attenuates motor neuron loss in the SOD1 G93A mouse model of amyotrophic lateral sclerosis.
    Jiang HQ; Ren M; Jiang HZ; Wang J; Zhang J; Yin X; Wang SY; Qi Y; Wang XD; Feng HL
    Neuroscience; 2014 Sep; 277():132-8. PubMed ID: 24699224
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.